HOME >> MEDICINE >> NEWS
Diagnosis of rhinitis and atopical dermatitis

This was the conclusion of Ana Mara Irujo Andueza in her PhD thesis defended recently at the Public University of Navarra.

8,607 children in 66 centres

The most common atopical illnesses in infancy are, besides asthma, atopical dermatitis and allergic rhinitis. Studies of a multicentre nature have shown a significant rise in these ailments throughout the world and the causes of the increase are, as yet, not sufficiently clear.

Within this context, the aim of the PhD thesis was to evaluate the prevalence of allergic rhinitis and atopical dermatitis amongst the school population in the area around Pamplona, the capital of Navarre, using parameters as sex, language, date of birth and school. The data obtained was compared with a previous study undertaken in 1994 in the same geographical zone, and against those carried out at other centres at a national and international level as part of the third phase of the International Study of Asthma and Allergies in Childhood (ISAAC).

In 2001 Ana Mara Irujo carried out a transversal epidemiological study - using questions from the ISAAC on two populations of children, a group between 6- and 7- year-olds and another between 12 and 14, both groups being drawn from 66 schools and colleges, mostly in the Pamplona-Irunea city area but also from centres in Baraain, Zizur Mayor, Zizur Menor, Atarrabia, Huarte, Burlada and Mutilva Baja.

The first signs of asthma

Rhinitis and atopical dermatitis are considered to be "the first signs of asthma". The expression "allergic triad" is used to refer to dermatitis followed by rhinitis and ending up with asthma. The rhinitis is characterised by an increase in nasal secretion, also normally associated with conjunctival factors of the eyes that significantly affect the quality of life, given that exercise and physical activity in general are affected.

According to the study, for the group of 6- and 7-year olds, the current fr
'"/>

Contact: Garazi Andonegi
garazi@elhuyar.com
34-94-336-3040
Elhuyar Fundazioa
7-Oct-2005


Page: 1 2 3

Related medicine news :

1. Diagnosis and referrals for kidney disease fall well short of need, Johns Hopkins study shows
2. Diagnosis and treatment of osteoporosis falls shortnon adherence compounds issue
3. Allergic rhinitis associated with impaired sleep quality
4. Tobacco smoke linked to allergic rhinitis in infants

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diagnosis rhinitis and atopical dermatitis

(Date:12/17/2014)... -- Expectant parents should leave prenatal picture-taking to medical ... Use of ultrasound imaging and heartbeat monitors to get ... agency warns. "Although there is a lack ... and heartbeat monitors, prudent use of these devices by ... FDA biomedical engineer, said in an agency news release. ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... America, and work commitment is a big reason why, new ... said Dr. Mathias Basner, an assistant professor of sleep and ... of Medicine. A time-use survey of nearly 125,000 Americans, ... main activity exchanged for sleep. Short sleepers -- those who ...
(Date:12/15/2014)... 15, 2014 South Florida’s leading urgent care ... can be a daze of hassle, hustle, and bustle that ... decking halls, to burns when making special meals and heartburn ... can happen at any time. To prevent this season of ... made a list of helpful and healthful holiday tips to ...
(Date:12/15/2014)... News) -- Expert pilots process visual information more efficiently ... better decisions during landings, a new study shows. ... pilots to master, and 36 percent of all airplane ... final approach and landing. Researchers monitored the brain ... pilots while they were at the controls of a ...
(Date:12/15/2014)... 15, 2014 At the leading, long-established ... AutismOne and Focus Autism will welcome ... research on the effects of toxins to children’s health, ... information. , Luminaries such as Dr. Lucija Tomljenovic ... with esteemed, credentialed colleagues of the United States to ...
Breaking Medicine News(10 mins):Health News:FDA Warns Against Fetal 'Keepsake' Videos 2Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:MD Now Urgent Care Presents Healthy Holiday Tips 2Health News:MD Now Urgent Care Presents Healthy Holiday Tips 3Health News:Study Shows Why Expert Pilots Are Experts 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 2Health News:AutismOne and Focus Autism Collaborate on Scientific Conference; International Group of Researchers to Present in Chicago, May 2015 3
(Date:12/17/2014)... HOLBROOK, N.Y. , Dec. 17, 2014 /PRNewswire/ ... that The Depository Trust Company (DTC) has made ... the Deposit Chill on the Company,s stock effective ... of Northstar,s common stock for depository and book ... and the Company is now once again fully ...
(Date:12/17/2014)... MILAN , December 17, 2014 ... becoming nothing less than a hub of information concerning the ... A further addition to the recently launched ... world and has now been enriched by a new chapter ... A richly detailed and panoramic hub on ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014  RXi ... biotechnology company focused on discovering, developing and commercializing ... RNA-targeted technologies, today announced completion of enrollment in its ... from the 3-month observations confirmed the 1-month findings ... Logo - http://photos.prnewswire.com/prnh/20130917/NE80755LOGO ...
Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 2RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 3RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 4RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of Enrollment for its Phase 2a Trial RXI-109-1301 5
Cached News: